Bioventus (BVS) Q4 2024 Annual Earnings
BVS·Reported March 11, 2025·Before market open
Bioventus reported Q4 2024 revenue of $153.6M, beat analyst consensus of $124.5M by $29.1M. Diluted EPS came in at $0.15, beat the $0.08 consensus by $0.07.
Revenue
$153.6Mbeat by $29.1M
Consensus: $124.5MDiluted EPS
$0.15beat by $0.07
Consensus: $0.08
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Bioventus's Q4 2024 earnings report.
Bioventus (BVS) reported Q4 2024 earnings on March 11, 2025 before market open.
Bioventus reported revenue of $153.6M and diluted EPS of $0.15 for Q4 2024.
Revenue beat the consensus estimate of $124.5M by $29.1M. EPS beat the consensus estimate of $0.08 by $0.07.
You can read the 10-K periodic report (0001628280-25-011831) directly on SEC EDGAR. The filing index links above go to sec.gov.